Acta 1851, 10831094
In recent studies, HLA-A*33:01 was associated with DILI due to ticlopidine (OR, 163.1), methyldopa (OR, 97.8), fenofibrate (OR, 58.7), terbinafine (OR, 40.5), enalapril (OR, 34.8), sertraline (OR, 29), and erythromycin (OR 10.2) in GWASs of persons of European descent
(186) showed, using oligofructose as an example, that giving patients with MASH a supplement of the prebiotic can improve their liver steatosis and non-alcoholic fatty liver activity score (NAS) (186)
The findings were groundbreaking: at the 6-month mark, subjects taking the 1,000 mg daily dose experienced a 30% to 35% increase in glutathione levels within their erythrocytes (red blood cells), plasma, and lymphocytes